Skip to content

Adherence predicts viral failure just as well as CD4 count change, South African study shows

Does tenofovir increase the risk of efavirenz-associated liver side-effects?

Dual class drug resistance present in two-thirds of South African HIV cohort on failing ART

Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries

Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries

ART recommended for all with CD4 counts below 350, say South African doctors

Start anti-HIV treatment with a CD4 cell count of 350 with efavirenz and Truvada, say draft British guidelines

CROI: Risk of second virological failure has declined since 1996, but risk of death remains stable

WHO expert panel wants fewer second-line ART choices